Close Menu

Somalogic

NEW YORK (GenomeWeb News) – SomaLogic, New England Biolabs, and Gilead Sciences are suing Enzymatics in federal court for patent infringement.

Proteomics diagnostics firm Somalogic reported data this week supporting the utility of its blood-based 13-protein panel for the detection of malignant mesothelioma.

Quest Diagnostics has begun offering a test for measuring free epidermal growth factor receptor using Somalogic's aptamer-based Somamer technology.

Life Technologies said this week that it plans to accelerate development of its Ion Torrent technology for proteomic applications.

SomaLogic has released SomaSuite, a software tool that provides access to multiplexed proteomic data generated by SomaLogic's Somascan proteomics assay technology.

Aushon Biosystems announced this week its plans to launch a new multiplex protein biomarker platform.

By Adam Bonislawski
Somalogic last week published in PLoS One a study offering the first data on use of its aptamer-based Somascan platform in tissue samples.

By Adam Bonislawski
Researchers at the University of Pittsburgh Cancer Institute have identified a panel of ten serum protein markers that could be used in risk assessment and the early detection of lung cancer.

Pages

The Hill reports President Donald Trump issued an executive directing federal agencies to cut the number of board and advisory committees they have.

The New York Times reports that researchers are combining tools to more quickly develop crops to feed a growing population and cope with shifting climates.

Scientists in Canada are looking to the UK's plan to sequence children with rare conditions for inspiration, the National Post reports.

In PNAS this week: copy number changes arose during polar bear evolution, genomic and transcriptomic analysis of the Siberian hamster, and more.